Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
Wake County is under alert.
Program
On WRAL at 11: Storms rolling through Sunday night. We'll tell you if they'll affect your Labor Day plans in the morning
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novartis Ag ADR
(NY:
NVS
)
120.89
+0.47 (+0.39%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novartis Ag ADR
< Previous
1
2
...
22
23
24
25
26
27
28
29
Next >
Visualizing the World’s Biggest Pharmaceutical Companies
September 17, 2021
Some of the world’s biggest pharmaceutical companies have played a central role in the COVID-19 pandemic.
Via
Talk Markets
Exposures
COVID-19
Novartis' Prostate Cancer Therapy Linked To Improved Quality Of Life
September 17, 2021
Novartis AG (NYSE: NVS) is building the case for its radioligand therapy, 177Lu-PSMA-617. With positive Phase 3 primary endpoint data in the bag, Novartis at the European...
Via
Benzinga
Zymeworks' Zanidatamab Aces Mid-Stage Esophageal Cancer Trial
September 16, 2021
At the European Society of Medical Oncology Congress 2021 (ESMO21), Zymeworks Inc (NYSE: ZYME) presented encouraging early data on its HER2‑targeted bispecific antibody. Twenty-...
Via
Benzinga
Better Pharmaceutical Stock: Apellis or Novartis?
September 15, 2021
The pharmaceutical industry is expected to remain in the limelight as companies race to develop new medicines catering to mild diseases and critical ailments.
Via
Talk Markets
CureVac Shares Fall After Cutting COVID-19 Vaccine Production Plans
September 14, 2021
CureVac BV has canceled contract manufacturing deals for its experimental COVID-19 vaccine with two prospective partners.
Via
Talk Markets
Exposures
COVID-19
What may be behind achy, tired, or burning eyes? Dry eye disease may be the culprit.
September 09, 2021
(BPT) - Sponsored by Novartis Pharmaceuticals Corporation.
Via
Brandpoint
Exposures
COVID-19
Understanding Novartis's Unusual Options Activity
August 10, 2021
Novartis (NYSE:NVS) shares experienced unusual options activ...
Via
Benzinga
CureVac Shares Fall After Cutting COVID-19 Vaccine Production Plans
September 14, 2021
CureVac BV (NASDAQ: CVAC) has canceled contract manufacturing deals for its experimental COVID-19 vaccine with two prospective partners. The Company would...
Via
Benzinga
Exposures
COVID-19
Why Regenxbio Stock Is Way Up Today
September 13, 2021
American biopharmaceutical giant AbbVie wants access to Regenexbio's gene therapy for macular degeneration.
Via
The Motley Fool
ADHD Drug Developer Cingulate Plans NASDAQ Debut
September 10, 2021
Cingulate Inc filed for an IPO, penciling in a modest $58 million raise, and expects to list on NASDAQ under CING ticker. Cingulate has a Phase 3-ready attention...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Why Did Wedbush Downgrade Xoma?
September 07, 2021
Wedbush has cut XOMA Corporation (NASDAQ: XOMA) to neutral from outperform and lowered its price target to $22 from $41. Analyst Liana Moussatos notes ...
Via
Benzinga
Novartis Stops Iscalimab Trial In Kidney Transplant Patients
September 03, 2021
Novartis AG (NYSE: NVS) has halted a Phase 2 trial of CFZ533 (iscalimab) in kidney transplant patients. The decision follows interim data that showed iscalimab was...
Via
Benzinga
Price Over Earnings Overview: Novartis
September 02, 2021
Looking into the current session, Novartis Inc. (NYSE:NVS) is trading at $92.23, after a 0.45% drop. Over the past month, the stock decreased by 0.02%, but over the...
Via
Benzinga
The Rising Delta Variant
September 01, 2021
China is not only cracking down on kiddie playtime. It also is absorbing bankruptcy claims from real estate developer Evergrande.
Via
Talk Markets
Topics
Bankruptcy
Exposures
Financial
Legal
Novartis, NHS England Ink Access Deal For Cholesterol Drug Leqvio
September 01, 2021
The U.K. government, NHS England, and Novartis AG (NYSE: NVS) unveiled a "world-first" reimbursement deal for providing broader access to anti-cholesterol...
Via
Benzinga
UCB Gets EU Approval For Bimekizumab In Psoriasis
August 25, 2021
The European Commission has cleared UCB's (OTC: UCBJF) Bimzelx (bimekizumab) for moderate to severe plaque psoriasis in adults. UCB's confidence lies in...
Via
Benzinga
Living with Chronic Hives: One Woman’s Story
August 25, 2021
(BPT) - Ilana, a board-certified emergency medicine physician, lived with chronic hives for almost as long as she can remember. 'I've had them since I was at least 8 years old,' she says. 'It's...
Via
Brandpoint
Exposures
Product Safety
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
August 25, 2021
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Exposures
COVID-19
Novartis' STAMP Inhibitor Under FDA Review For Myeloid Leukemia
August 25, 2021
The FDA has accepted for review Novartis AG's (NYSE: NVS) marketing application seeking approval for asciminib (ABL001) in chronic myeloid leukemia (CML)....
Via
Benzinga
Exposures
Product Safety
Only The Conservative Pot Stocks Index Is Up YTD And Currently Yields 4.9%
August 25, 2021
If you were to invest in a basket of the major companies that have bought into marijuana companies you could possibly generate greater returns than only owning the associated marijuana company.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
August 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...
Via
Benzinga
Exposures
Product Safety
Novartis's Kymriah Flunks In Late-Stage NHL Study
August 24, 2021
Novartis AG's (NYSE: NVS) Kymriah (tisagenlecleucel) CAR-T therapy failed to meet its primary endpoint of event-free survival in a Phase 3 study in aggressive...
Via
Benzinga
Now That The FDA Approved Pfizer-BioNTech, Is This It For Vaccine Stocks?
August 23, 2021
If there's one thing to take away from any conversation about biotech stocks, it's that any company with their hat in the ring is likely making a version of something they hope to be better than the...
Via
Talk Markets
Exposures
Product Safety
BEE Hits 10K Subscribers for BEE Pro, Company Poised to Accelerate Growth in H2
August 18, 2021
Companies such as Netflix, Harpercollins, Boston College, Novartis, Unicef, and Save the Children rely on BEE Pro to speed up & streamline email and landing page design.
Via
News Direct
Novartis Shares Two Year Beovu Data From Diabetic Macular Edema Studies
August 17, 2021
Novartis AG (NYSE: NVS) has reported data from two Phase 3 trials assessing Beovu (brolucizumab) 6 mg versus Regeneron Pharmaceuticals Inc's (NASDAQ: REGN...
Via
Benzinga
The Real World
August 11, 2021
The rise of the delta has caused markets to drop back after the rises earlier although inflation still remains within a point or two of forecasts at 5.3-5.4% annualized.
Via
Talk Markets
WHO-Led Study To Test Three Anti-Inflammatory Drugs For COVID-19
August 11, 2021
The World Health Organization (WHO) is set to start trials of three anti-inflammatory drugs to contain the spread of coronavirus to see if they can improve the...
Via
Benzinga
Exposures
COVID-19
2 Dividend Stocks to Buy and Hold for Years
August 10, 2021
The stock market is experiencing substantial volatility due to concerns over high inflation and the worldwide spread of the COVID-19 Delta variant.
Via
Talk Markets
Exposures
COVID-19
4 Steps You Can Take to Manage Heart Failure
August 06, 2021
(BPT) - Managing a chronic condition like heart failure (HF) can be challenging, especially as our society adapts to a new sense of normalcy. But with HF, management is crucial at all times. The good...
Via
Brandpoint
Exposures
Product Safety
< Previous
1
2
...
22
23
24
25
26
27
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.